NTLA : Intellia Therapeutics stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)

The 3 Wall Street analysts offering Intellia Therapeutics stock forecast in the last 6 months have average price target of $90.33 with a high forecast of $106.0 and a low forecast of $80.0. The average Intellia Therapeutics stock forecast represents a 26.58% increase from the last price of $71.36. From AI system, total return is 2091.27% from 1692 forecasts. For Intellia Therapeutics stock forecast 2021, 7 predictions are offered for each month of 2021 with average Intellia Therapeutics stock forecast of $72.39, a high forecast of $73.93, and a low forecast of $71.45. The average Intellia Therapeutics stock forecast 2021 represents a 1.45% increase from the last price of $71.36. For Intellia Therapeutics stock forecast 2022, 12 predictions are offered for each month of 2022 with average Intellia Therapeutics stock forecast of $82.66, a high forecast of $91.66, and a low forecast of $74.75. The average Intellia Therapeutics stock forecast 2022 represents a 15.83% increase from the last price of $71.36. For Intellia Therapeutics stock forecast 2025, 12 predictions are offered for each month of 2025 with average Intellia Therapeutics stock forecast of $101.86, a high forecast of $102.17, and a low forecast of $101.55. The average Intellia Therapeutics stock forecast 2025 represents a 42.74% increase from the last price of $71.36. For Intellia Therapeutics stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Intellia Therapeutics stock forecast of $102.42, a high forecast of $102.56, and a low forecast of $102.22. The average Intellia Therapeutics stock forecast 2026 represents a 43.52% increase from the last price of $71.36. For Intellia Therapeutics stock forecast 2030, 12 predictions are offered for each month of 2030 with average Intellia Therapeutics stock forecast of $102.88, a high forecast of $102.94, and a low forecast of $102.83. The average Intellia Therapeutics stock forecast 2030 represents a 44.17% increase from the last price of $71.36. For Intellia Therapeutics stock forecast 2031 (10 year), 5 predictions are offered for each month of 2031 with average Intellia Therapeutics stock forecast of $102.97, a high forecast of $102.98, and a low forecast of $102.95. The average Intellia Therapeutics stock forecast 2031 represents a 44.29% increase from the last price of $71.36. Please, see more forecasts below.